2022/05/06 ALA-1000 印度專利核准在案,證書號數為389012號。
在〈2022/05/06 ALA-1000 印度專利核准在案,證書號數為389012號。〉中留言功能已關閉
2022 年 5 月 6 日
Single-ascending-dose (SAD) study successfully demonstrated the safety, tolerability, and sustained release profile at least 3 months resulting from ALA-1000 injection in patients with opioid dependence.